跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
劉 興璟
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0003-4929-7231
電子郵件
63063
w.tmu.edu
tw
h-index
1492
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2022
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(47)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 H-Eugene Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Epidermal Growth Factor Receptor
76%
Acute Myeloid Leukemia
75%
Non Small Cell Lung Cancer
66%
Chemotherapy
34%
Malignant Neoplasm
32%
Human Papillomavirus
28%
Lung Adenocarcinoma
27%
Disease
26%
Cisplatin
25%
Telomerase Reverse Transcriptase
23%
Drug Resistance
23%
Arsenite
21%
Liver Cell Carcinoma
21%
Paclitaxel
21%
Tubulin
21%
Uridine Diphosphate
21%
Interleukin 10
21%
Thalassemia
21%
Interferon
21%
Overall Survival
19%
Epidermal Growth Factor Receptor Kinase Inhibitor
19%
Tuberculostatic Agent
19%
Pharmacokinetics
17%
Mouse
16%
Respiratory Tract Inflammation
16%
Interleukin 12
16%
Chronic Myeloid Leukemia
16%
Erlotinib
15%
Human Papillomavirus Type 16
14%
Cytotoxicity
13%
Brain Metastasis
13%
Prevalence
13%
Cytokine
13%
Progression Free Survival
12%
Adenoviridae
12%
Leukemia
12%
Carboplatin
12%
Papillomavirus Infection
11%
Tumor Necrosis Factor
11%
Protein Tyrosine Kinase Inhibitor
11%
Neoplasm
11%
Areca Nut Extract
10%
Oncoprotein
10%
Mucocutaneous Lymph Node Syndrome
10%
Therapeutic Effect
10%
Hepatotoxicity
10%
Synapsin I
10%
Hemoglobin Variant
10%
Pemetrexed
10%
Medicine and Dentistry
Lung Cancer
76%
Epidermal Growth Factor Receptor
58%
Acute Myeloid Leukemia
53%
Non Small Cell Lung Cancer
43%
Leukemia Cell
34%
Programmed Cell Death
33%
Myeloid Differentiation
25%
Disease
25%
down Regulation
23%
Brain Metastasis
22%
In Vitro
21%
Personalized Medicine
21%
Oncogene C Myc
21%
Cell Cycle Arrest
18%
Progression Free Survival
16%
Erlotinib
15%
Drug Resistance
13%
Chronic Myelogenous Leukemia
12%
Cancer Cell
12%
Lung Adenocarcinoma
12%
Carboplatin
12%
Cisplatin
12%
Prevalence
11%
Tyrosine-Kinase Inhibitor
11%
Low Drug Dose
10%
Wart Virus
10%
Imatinib
10%
Pooled Analysis
10%
Molecular Diagnosis
10%
microRNA
10%
Human Papillomavirus Type 16
10%
Brain Radiation
10%
Synapsin I
10%
Systematic Review
10%
Kawasaki Disease
10%
Meta-Analysis
10%
Pemetrexed
10%
Acetylsalicylic Acid
10%
Deep Vein Thrombosis
10%
Bone Marrow Stromal Cell
10%
Thalassemia
10%
Point Mutation
10%
Glutathione
10%
Coagulopathy
10%
Arsenic Trioxide
10%
Nephrotoxicity
10%
Leukemia
10%
Thymocyte
10%
Sodium Valproate
10%
Cell Growth
10%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
62%
Myeloid
53%
Oncogene C Myc
43%
Polymerase Chain Reaction
34%
Wart Virus
32%
Allele
22%
Pharmacokinetics
22%
down Regulation
22%
Genome Sequencing
21%
Hope
21%
Translating (Language)
21%
Small Molecule
21%
Point Mutation
21%
Hemoglobin Variant
21%
Pharmacogenomics
21%
Telomerase Reverse Transcriptase
21%
CD34
18%
K562 Cells
14%
Overall Survival
14%
Cisplatin
13%
Human Papillomavirus Type 16
12%
Prevalence
12%
Drug Resistance
12%
Cancer Cell
12%
Medical Record
11%
Transfer Gene
10%
2-Methoxyestradiol
10%
Imatinib
10%
Uridine Diphosphate
10%
Mean Corpuscular Volume
10%
Hemocyte
10%
Cell Cycle Arrest
10%
Genotyping
10%
Chemosensitivity
10%
Exon
10%
Autosomal Recessive Disorder
10%
Hemoglobin Electrophoresis
10%
Lipid
10%
MicroRNA
10%
Globin
10%
Coagulopathy
10%
Thrombocytosis
10%
Synapsin I
10%
Polymerase Chain Reaction
10%
Genetic Risk
10%
Iron-Deficiency Anemia
10%
Hemoglobins
10%
Case-Control Study
10%
Erlotinib
10%
Deep Vein Thrombosis
10%
